Login / Signup
Fenebrutinib and BTK inhibition: Unveiling a new target for the treatment of chronic spontaneous urticaria.
Alvaro Carvallo
Sergio Sánchez-Fernández
María de la Paz Morales-Palacios
Published in:
Allergy (2022)
Keyphrases
</>
tyrosine kinase
replacement therapy